Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
25.2M
-
Shares change
-
+4.38M
-
Total reported value, excl. options
-
$418M
-
Value change
-
+$68.4M
-
Put/Call ratio
-
0.95
-
Number of buys
-
73
-
Number of sells
-
-32
-
Price
-
$16.60
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2017
116 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q4 2017.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.2M shares
of 55.5M outstanding shares and own 45.4% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (9.39M shares), FMR LLC (3.29M shares), BB BIOTECH AG (1.54M shares), BlackRock Inc. (1.21M shares), Casdin Capital, LLC (1.14M shares), Vanguard Group Inc (951K shares), EVENTIDE ASSET MANAGEMENT, LLC (703K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (655K shares), FARALLON CAPITAL MANAGEMENT LLC (655K shares), and Laurion Capital Management LP (463K shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.